Small implantable devices that plug a sac in the heart where clots are formed provide a safer alternative for patients who can't take blood thinners.
"The ability to give the patient a one stop fix where you don't have to worry about blood thinning is quite a game changer." It will be assessed as the first line of defence against stroke and compared to the use of newer blood-thinning agents. The global trial is recruiting 3000 patients and Sydney's St Vincent's Hospital is leading the Australian arm.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: